optimizing patient selection for antibody drug conjugates in breast cancer
Published 1 month ago • 35 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
0:41
the importance of patient selection in breast cancer trials
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
3:23
antibody-drug conjugates in the treatment of solid tumors
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
2:00
advances in antibody-drug conjugates for breast cancer at esmo 2022
-
0:46
antibody-drug conjugates in gynecological cancers
-
2:40
emergence of antibody-drug conjugates in metastatic breast cancer: 2022 esmo florida
-
2:11
next-generation antibody-drug conjugates in her2 breast cancer
-
1:02
combination therapies incorporating adcs in breast cancer
-
1:58
what’s next for antibody drug conjugates in urothelial carcinoma?
-
6:51
adcs for her2 and her2-low breast cancer
-
2:21
adcs for the treatment of her2-low breast cancer
-
35:25
antibody drug conjugates and recent applications in breast cancer treatment
-
1:37
how can we best sequence adcs in breast cancer?
-
2:03
recent antibody-drug conjugate approvals in gynecologic malignancies
-
3:58
antibody drug conjugates in lung cancer
-
18:25
emerging antibody-drug conjugates in breast cancer: an expert analysis of promising therapies
-
1:09
where are we in sequencing adcs in hr breast cancer?